Search Results

Head and Neck Malignant Paragangliomas: Experience from a Single Institution.

• Authors : Ding, Yiming; Li, Lifeng; Han, Demin

Subjects: TREATMENT of rare diseases; HEAD & neck cancer; PARAGANGLIOMACHINA

• Source: ENT: Ear, Nose & Throat Journal. May2024, Vol. 103 Issue 5, p298-304. 7p.

Record details

Risk factors for ifosfamide nephrotoxicity in children.

• Authors : Skinner, Roderick; Pearson, Andrew D.J.

Subjects: NEPHROTOXICOLOGY

• Source: Lancet. 8/31/1996, Vol. 348 Issue 9027, p578. 3p. 1 Chart, 1 Graph.

Record details

An Unusual Parotid Mass in a 14-Year-Old Female.

• Authors : Leavitt, Taylor; Shah, Avanthi Tayi; Singh, Vivekanand

Subjects: TEMPOROMANDIBULAR joint; TRIGEMINAL nerve diseases; COMPUTED tomography

• Source: ENT: Ear, Nose & Throat Journal. Jul2024, Vol. 103 Issue 7, p403-405. 3p.

Record details

Small-round-cell tumours of childhood.

Subjects: TUMORS in children

• Source: Lancet. 9/10/1994, Vol. 344 Issue 8924, p725. 5p. 2 Color Photographs, 3 Black and White Photographs, 1 Diagram, 1 Chart.

Record details

PANCDR: precise medicine prediction using an adversarial network for cancer drug response.

• Authors : Kim, Juyeon¹ (AUTHOR); Park, Sung-Hye^2,3 (AUTHOR); Lee, Hyunju^1,4 (AUTHOR)

Subjects: MACHINE learning; ANTINEOPLASTIC agents; PREDICTION models

• Source: Briefings in Bioinformatics. Mar2024, Vol. 25 Issue 2, p1-10. 10p.

Record details

MarketLine Company Profile: Shionogi & Co., Ltd.

Subjects: *PHARMACEUTICAL industryJAPANSHIONOGI & Co. Ltd.

• Source: Shionogi & Co., Ltd. MarketLine Company Profile. 11/2/2023, p1-38. 38p.

Record details

Serious side effects.

Subjects: DRUG side effectsUNITED States

• Source: Urology Times. Mar95, Vol. 23 Issue 3, p13. 1/8p.

Record details

MarketLine Company Profile: Shionogi & Co., Ltd.

Subjects: *PHARMACEUTICAL industryJAPANSHIONOGI & Co. Ltd.

• Source: Shionogi & Co., Ltd. MarketLine Company Profile. 10/6/2022, p1-35. 35p.

Record details

MarketLine Company Profile: Shionogi & Co., Ltd.

Subjects: *PHARMACEUTICAL industryJAPANSHIONOGI & Co. Ltd.

• Source: Shionogi & Co., Ltd. MarketLine Company Profile. 12/29/2021, p1-32. 32p.

Record details

RNCE: network integration with reciprocal neighbors contextual encoding for multi-modal drug community study on cancer targets.

• Authors : Chen, Junyi¹ (AUTHOR); Wong, Ka-Chun¹ (AUTHOR)

Subjects: *ALGORITHMS; DRUG target; ANTINEOPLASTIC agents

• Source: Briefings in Bioinformatics. May2021, Vol. 22 Issue 3, p1-12. 12p.

Record details